Abdominal Transcutaneous Electrical Acupoint Stimulation on Children With Autism Spectrum Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-6
SponsorFirst Affiliated Hospital Xi'an Jiaotong University

About this trial

The goal of this clinical trial is to learn if abdominal transcutaneous electrical acupoint stimulation (abdominal TEAS) works to treat autism spectrum disorder (ASD) in children. It will also learn about the safety of abdominal TEAS. The main questions it aims to answer are:

Does abdominal TEAS a safe and effective treatment for children with autism spectrum disorder and gastrointestinal symptoms? Researchers will compare abdominal TEAS to a placebo (a sham abdominal TEAS without stimulation) to see if abdominal TEAS works to treat ASD.

Participants will:

Take abdominal TEAS or sham abdominal TEAS 5 days a week for 8 weeks. Visit the clinic once every 4 weeks for checkups and tests Keep a diary of their symptoms.

Eligibility criteria

Qualifiers

Being diagnosed as autism based on the DSM-V and Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)

Aged 3 to 6 years

Disqualifiers

Diagnosed with other organic diseases (such as severe hearing and visual impairment, brain trauma) and neurological disease (e.g., epilepsy, Rett syndrome), or psychiatric disorder (schizophrenia, bipolar affective disorder, etc)

Oral or injected antibiotics within 30 days before screening

History of acupuncture, electroacupuncture, TEAS treatment before screening

Taking antipsychotic drugs and psychobiotic supplements within 30 days before screening

Trial design

Treatments tested in this trial

  • abdominal transcutaneous electrical acupoint stimulation (abdominal TEAS)

Treatment groups

42 Participants
are divided into 2 treatment groups

Sponsors and collaborators